BIMI International Medical Inc. Common Stock
BIMI
BIMI was delisted on the 21st of August, 2024.
4 hedge funds and large institutions have $7.36K invested in BIMI International Medical Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
71% less capital invested
Capital invested by funds: $25.5K → $7.36K (-$18.1K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$727 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$6.54K |
| 2 |
Morgan Stanley
New York
|
-$1.87K |
BIMI Hedge Fund Activity: Q3 2019 in Review
4 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in BIMI International Medical Inc. Common Stock (BIMI) for Q3 2019, worth a combined $7.36K — down 71% from $25.5K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BIMI positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $727. The largest seller was Deutsche Bank, cutting an estimated $6.54K.
- 4 institutional investors held BIMI International Medical Inc. Common Stock (BIMI) as of Q3 2019, up from 3 in Q2 2019.
- Funds reported $7.36K of BIMI International Medical Inc. Common Stock stock for Q3 2019, down 71% quarter-over-quarter.
- 1 fund opened new BIMI International Medical Inc. Common Stock positions in Q3 2019 and 0 closed out, a net change of +1 holder.
- The largest BIMI International Medical Inc. Common Stock buyer in Q3 2019 was UBS Group, an estimated $727 added.
- The largest BIMI International Medical Inc. Common Stock seller in Q3 2019 was Deutsche Bank, an estimated $6.54K sold.
Based on aggregated 13F filings for Q3 2019.